LAIR2 and hypothyroidism: Importantly, the analysis also revealed that serum LAIR-2 mRNA distinguished all hypothyroid group, clinical, and subclinical patients (Fig. 3E–G) from healthy controls with a sufficient performance power (AUC = 0.8, 0.9, and 0.71, respectively) and with an excellent discrimination of clinical hypothyroidism.